The present study monitored the expression level of ACE2, the host cell receptor for SARS-CoV-2, and found that ACE2 protein is upregulated in the brains of patients with Alzheimer’s disease. The gene discussed is ACE2; the disease is early-onset autosomal dominant Alzheimer disease.